CoChat

Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure

Open access
Matichard, E, Verpillat, P, Meziani, R, Gérard, B, Descamps, V, Legroux, E, Burnouf, M, Bertrand, G, Bouscarat, F, Archimbaud, A, Picard, C, Ollivaud, L, Basset-Seguin, N, Kerob, D, Lanternier, G, Lebbe, C, Crickx, B, Grandchamp, B, Soufir, N · 2004 · Journal of Medical Genetics
Cited by 136

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

alignant melanoma (MM) is increasing in most Caucasian populations, the incidence doubling every 10 years. 1 Multiple phenotypic risk factors, including the number of melanocytic naevi (moles), freckling, dysplastic naevi, propensity to sunburn, and the number of severe sunburn episodes during youth, have been identified in the aetiology and pathogenesis of this disease.2 Approximately 10% of MM cases occur in kindreds, suggesting hereditary predisposition to melanoma, often in association with the atypical mole syndrome (AMS) phenotype.Germline mutations affecting two highly penetrant genes predisposing to melanoma, CDKN2A and Cdk4, have been associated with an increased risk for the development of familial cutaneous melanoma.[3][4][5][6] However, these mutations are found in only 30 to 40% of kindreds, indicating that other genes may predispose to MM.In addition to the major predisposition to melanoma caused by these genes, polygenic inheritance determining the development of melanoma has been shown to depend upon polymorphisms located on genes controlling different cellular pathways such as DNA repair, 7 pigmentation, 8 and reactive oxygen detoxification.9 10 Among these, loss of function variants of the human melanocortin 1 receptor gene (MC1R), which plays a crucial role in pigmentation, 11 12 seems important in determining MM risk.8 13 MC1R maps to chromosome 16q24.3and encodes a G protein coupled receptor with seven transmembrane domains expressed on many cell types, 14 including melanocytes.MC1R is the receptor of two melanocortin peptides synthesised in the pituitary gland, alpha melanocyte stimulating hormone (a-MSH) and ACTH.These have the same affinity for MC1R, and are cleavage products of the large precursor peptide propiomelanocortin.Their binding to this receptor activates adenylate cyclase, increases intracellular c-AMP production, then leads to enhanced tyrosinase transcription and traduction, and, ultimately, to production of photoprotective eumelanin and melanocyte proliferation.Regulation of melanogenesis also depends on many paracrine factors, such as agouti signalling protein (ASP), an MC1R antagonist, and endothelin 1. 15 16 Recently, the physiological role of ASP in the regulation of human pigmentation has been suggested.This role may be through the association of a polymorphism, localised 25bp downstream of the TGA termination codon in the non coding exon 4 of the ASP gene, with dark hair and eye colours in a Caucasian population from Pennsylvania.17 Recent investigations have demonstrated that MC1R is highly polymorphic in the Caucasian population.12 18 19 About 30 variants have been described, of which nine have been demonstrated to be loss of function variants.20 21 Some of these variants (Val60Leu, Ile40Thr, Arg142His, Arg151Cys, Arg162Pro, Arg160Trp, and Asp294His) are unable to stimulate cAMP production as strongly as the wild type receptor in response to a-MSH stimulation, 22-26 whereas others (Val122Met) demonstrate a decreased a-MSH binding affinity.25 Three MC1R variants alleles (Arg151Cys, Arg160Trp, and Asp294His) have been shown to be associated with the red hair and fair skin phenotype (RHC).RHC is characterised by fair pigmentation (fair skin, red hair, and freckles), and by sun sensitivity (poor tanning response and . . . . . . . . . . . . . . . . . . .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jmg.2003.011536

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 136

Metadata

Authors
Matichard, E., Verpillat, P., Meziani, R., Gérard, B., Descamps, V, Legroux, E., Burnouf, M., Bertrand, G., Bouscarat, F., Archimbaud, A., Picard, C., Ollivaud, L., Basset-Seguin, N., Kerob, D., Lanternier, G., Lebbe, C., Crickx, B., Grandchamp, B., & Soufir, N.
Venue
Journal of Medical Genetics
Publisher
BMJ
Published
2004-02
Volume
41
Issue
2
Pages
e13-e13
ISSN
  • 0022-2593 (ISSN-L)
  • 1468-6244
OpenAlex
W2133821784
Cited by
136
References
5
FWCI
5.10
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.